0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Cystic Fibrosis Therapeutics Market - Product Thumbnail Image

Cystic Fibrosis Therapeutics Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,150USDGBP
Montelukast Sodium Market - Product Thumbnail Image

Montelukast Sodium Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Epinephrine Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Epinephrine Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Tuberculosis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Tuberculosis Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
EUR$4,949USDGBP
From
EUR$2,789USDGBP
From
EUR$3,869USDGBP
From
EUR$3,869USDGBP
Chlorpheniramine Maleate Market Report and Forecast 2024-2032 - Product Thumbnail Image

Chlorpheniramine Maleate Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
EUR$4,949USDGBP
Sarcopenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Sarcopenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
  • Global
From
EUR$4,969USDGBP
From
EUR$4,969USDGBP
Bronchodilators Market Report and Forecast 2024-2032 - Product Thumbnail Image

Bronchodilators Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 140 Pages
  • Global
From
EUR$3,599USDGBP
From
EUR$3,599USDGBP
From
EUR$4,949USDGBP
From
EUR$4,949USDGBP
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more